Profile
Sapir Venture Partners is a pre-seed stage micro-venture capital firm based in Israel. Founded by Aaron Zucker, the firm is dedicated to supporting Israeli founders focused on frontier-tech, emphasizing science-driven and innovative deep technologies that promise impactful global change. The firm operates with a team composed of key figures such as Venture Partners and Founder Advisors, offering significant experience in building enduring ventures with ethical and transparent practices. They strive to act as co-founders with the entrepreneurs they support, aligning with their mission-driven focus and core values of creating significant positive change and ethical operation.
Sapir Venture Partners specializes in investing across sectors such as Deeptech, AI, Internet of Things (IoT), HealthTech, Software, and Frontier-Tech. They invest in pre-seed stages with an aim to catalyze transformative startups. The firm partners globally, with a strong focus on Israeli ventures, though its operations do not have a disclosed total Assets Under Management. Their overall investment philosophy is centered around creating meaningful value and fostering ventures that last.
Notable investments by Sapir Venture Partners include GlassBox, which successfully listed on TASE, DeepCure focusing on AI-driven drug discovery, Diptera (AI solutions for pest management), Enzymit (bio solutions for sustainable production), and Suridata, which was acquired. Their portfolio reflects a diverse commitment to cutting-edge technological advancements across several sectors.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.